DnB Asset Management AS purchased a new stake in Cryoport, Inc. (NASDAQ:CYRX – Get Rating) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 14,700 shares of the consumer goods maker's stock, valued at approximately $455,000.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. First Horizon Advisors Inc. lifted its stake in Cryoport by 132.3% in the 1st quarter. First Horizon Advisors Inc. now owns 1,080 shares of the consumer goods maker's stock worth $38,000 after acquiring an additional 615 shares in the last quarter. State of Tennessee Treasury Department purchased a new stake in Cryoport in the 1st quarter worth about $168,000. Fox Run Management L.L.C. purchased a new stake in Cryoport in the 1st quarter worth about $226,000. First Bank & Trust lifted its stake in Cryoport by 44.3% in the 1st quarter. First Bank & Trust now owns 6,767 shares of the consumer goods maker's stock worth $237,000 after acquiring an additional 2,079 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in Cryoport in the 4th quarter worth about $247,000. Institutional investors and hedge funds own 90.33% of the company's stock.
Get Cryoport alerts:Insider Activity at Cryoport
In other Cryoport news, Director Robert J. Hariri sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $43.29, for a total value of $86,580.00. Following the sale, the director now owns 7,911 shares of the company's stock, valued at approximately $342,467.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Cryoport news, Director Robert J. Hariri sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $43.29, for a total value of $86,580.00. Following the sale, the director now owns 7,911 shares of the company's stock, valued at approximately $342,467.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard J. Berman sold 2,708 shares of the firm's stock in a transaction that occurred on Tuesday, August 16th. The shares were sold at an average price of $43.05, for a total value of $116,579.40. Following the completion of the sale, the director now directly owns 107,203 shares in the company, valued at approximately $4,615,089.15. The disclosure for this sale can be found here. 9.70% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC raised their price target on Cryoport from $41.00 to $42.00 and gave the stock a "buy" rating in a research note on Tuesday, July 12th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $61.33.Cryoport Stock Down 3.0 %
Shares of CYRX stock opened at $27.20 on Friday. The stock's 50 day simple moving average is $35.66 and its 200 day simple moving average is $31.00. The company has a debt-to-equity ratio of 0.73, a quick ratio of 13.69 and a current ratio of 14.21. Cryoport, Inc. has a twelve month low of $19.82 and a twelve month high of $86.30. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -4.40 and a beta of 1.17.
Cryoport (NASDAQ:CYRX – Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The consumer goods maker reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.08). Cryoport had a negative net margin of 125.96% and a negative return on equity of 14.43%. The company had revenue of $64.20 million during the quarter, compared to the consensus estimate of $64.58 million. During the same period in the previous year, the business posted ($0.16) earnings per share. The firm's revenue was up 14.2% on a year-over-year basis. As a group, research analysts predict that Cryoport, Inc. will post -0.78 EPS for the current year.
Cryoport Company Profile
(Get Rating)
Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.
See Also
- Get a free copy of the StockNews.com research report on Cryoport (CYRX)
- What Steelcase's Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.